Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
The research team, led by Avik Som, an MD/PhD student, and Samuel Achilefu, PhD, professor of radiology and of biochemistry & molecular biophysics in the School of Medicine and of biomedical engineering in the School of Engineering & Applied Science, in collaboration with two labs in the School of Engineering & Applied Science, used two novel methods to create nanoparticles from calcium carbonate that were injected intravenously into a mouse model to treat solid tumors. The compound changed the pH of the tumor environment, from acidic to more alkaline, and kept the cancer from growing.
With this work, researchers showed for the first time that they can modulate pH in solid tumors using intentionally designed nanoparticles. Results of the research were recently published online in Nanoscale.
“Cancer kills because of metastasis,” said Som, who is working on a doctorate in biomedical engineering in addition to a medical degree. “The pH of a tumor has been heavily correlated with metastasis. For a cancer cell to get out of the extracellular matrix, or the cells around it, one of the methods it uses is a decreased pH.”
The researchers set out to find new approaches to raise the pH of the tumor and do so only in the tumor environment. In water, the pH in calcium carbonate increases as high as 9. But when injected into the body, the team discovered that calcium carbonate only raises the pH to 7.4, the normal pH in the human body. However, working with calcium carbonate presented some challenges.
“Calcium carbonate doesn’t like to be small,” Som said. “Calcium carbonate crystals are normally 10 to 1,000 times bigger than an ideal nanoparticle for cancer therapy. On top of that, calcium carbonate in water will constantly try to grow, like stalactites and stalagmites in a cave.”
To solve this issue, Som worked with other researchers in the School of Engineering & Applied Science to create two unique solutions. Teaming up with researchers in the lab of Pratim Biswas, PhD, the Lucy & Stanley Lopata Professor and chair of the Department of Energy, Environmental & Chemical Engineering, they developed a method using polyethyleneglycol-based diffusion to synthesize 20- and 300-nanometer-sized calcium carbonate.
Working with Srikanth Singamaneni, PhD, assistant professor of materials science, they developed another method to create 100-nanometer-sized calcium carbonate by building on a method known as ethanol-assisted diffusion. By harnessing the complementary expertise of the different labs, the researchers developed a solvent made of albumin to keep the calcium carbonate nanoparticles from growing, allowing them to be injected into the body intravenously.
Commonly, nanoparticles have been made with gold and silver. However, neither are present in the human body, and there are concerns about them accumulating in the body.
“Calcium and carbonate are both found heavily in the body, and they are generally non-toxic,” Som said. “When calcium carbonate dissolves, the carbonate becomes carbon dioxide and is released through the lungs, and calcium is often incorporated into the bones.”
Som and the team injected the calcium carbonate nanoparticles into the mouse fibrosarcoma model daily, which kept the tumor from growing. However, when they stopped injecting the nanoparticles, it started growing again.
Going forward, the researchers plan to determine the optimal dose to prevent metastasis, improve targeting to tumors and determine if it could be used with chemotherapy drugs.
The Latest on: Cancerous tumor
via Google News
The Latest on: Cancerous tumor
- Radon: Cancer-causing gas could be lurking in your home on February 18, 2019 at 2:58 pm
This time of year, many people are spending a lot more time indoors. With windows and doors shut tight, you could be putting your family at risk for radon poisoning. Radon is responsible for about 21, ... […]
- 'Cellular Barcoding' Reveals How Breast Cancer Spreads on February 18, 2019 at 1:38 pm
Cellular barcoding has been used to tag, track and pinpoint cells responsible for the spread of breast cancer from the main tumor into the blood and other organs, and also revealed how chemotherapy te... […]
- Man who survived 2 nights in North Dakota blizzard learns he has cancer while recovering in hospital on February 18, 2019 at 1:20 pm
A man who miraculously survived two nights inside his car during one of the Midwest's worse storms this winter learned while recovering in the hospital that he has stage 4 kidney cancer. William Mendo... […]
- Dry cleaning dangers: Cancer-causing solvent remains in use at dozens of Northeast Ohio dry cleaners on February 18, 2019 at 12:19 pm
"I thought it was a fantastic building right here in Fairview," he recalled. What his eyes didn’t see under Lorain Road nixed his property deal, he said. It also got him wondering. "It's one of those ... […]
- How to Treat Pancreatic Cancer on February 18, 2019 at 12:10 pm
There is no way to sugarcoat the fact that pancreatic cancer is very difficult to treat. Only about 20 to 30 percent of cases are found early enough to treat surgically, before the cancer has ... […]
- American Cancer Society holds Emerging Leaders Gala on February 18, 2019 at 11:52 am
MINNEAPOLIS — The American Cancer Society Emerging Leaders Gala is open to all young professionals and emerging leaders this Saturday. This is the 11th annual gala and will take place on Saturday, Feb ... […]
- KARE 11 INVESTIGATES: Vietnam veterans at risk for rare cancer on February 18, 2019 at 11:45 am
BLAINE, Minn. — A Minnesota family wants to warn other Vietnam veterans about a danger they discovered too late. They believe a parasite common in Southeast Asia caused a rare but deadly form of cance... […]
- Merck Gets Priority Review for Keytruda Combo in Kidney Cancer on February 18, 2019 at 8:27 am
Merck & Co., Inc. MRK announced that the FDA has granted priority review to yet another supplemental biologics license application (sBLA) for its PD-L1 inhibitor, Keytruda. In the latest sBLA ... […]
- Advancing therapy by measuring the 'games' cancer cells play on February 18, 2019 at 8:06 am
Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to ... […]
- Mom gets new tongue made from arm after cancer diagnosis on February 18, 2019 at 7:42 am
A 58-year-old woman who was reportedly faced with either surgically removing part of her tongue or succumbing to cancer within months has had a new one fashioned out of a vein and pieces of her arm. J... […]
via Bing News